A Phase 1 Study to Evaluate the Safety and Effectiveness of Using the Litx [talaporfin] BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Who Are Candidates for Interventional Therapy.

Trial Profile

A Phase 1 Study to Evaluate the Safety and Effectiveness of Using the Litx [talaporfin] BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Who Are Candidates for Interventional Therapy.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Jan 2015

At a glance

  • Drugs Talaporfin (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Light Sciences Oncology
  • Most Recent Events

    • 15 Jun 2010 Planned end date changed from 1 Aug 2009 to 1 May 2011 as reported by ClinicalTrials.gov.
    • 15 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 18 Apr 2009 Planned number of patients changed from 12 to 15 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top